Announcements Trials
Browse Landscape

Status

Active not recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 635Glioblastoma 566Glioma 405Neuroblastoma 174Neoplasms 123Astrocytoma 106Central Nervous System Neoplasms 103Medulloblastoma 87Breast Neoplasms 86Meningioma 82Carcinoma, Non-Small-Cell Lung 78Melanoma 77Lung Neoplasms 69Sarcoma 66Ependymoma 64Neurofibromatosis 1 63Recurrence 50Oligodendroglioma 48Neoplasm Metastasis 48Osteosarcoma 47Meningeal Carcinomatosis 46Rhabdomyosarcoma 45Diffuse Intrinsic Pontine Glioma 44Pheochromocytoma 43Rhabdoid Tumor 41Paraganglioma 41Gliosarcoma 40Sarcoma, Ewing 39Pancreatic Neoplasms 39Colorectal Neoplasms 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hydrocephalus × CNS × 1 year × Clear all
NCT04189172 2026-03-18

MiDura

Aesculap AG

Active not recruiting
328 enrolled
CNS

Arnold-Chiari Malformation, Brain Neoplasms, Hydrocephalus, Meningioma, Spinal Cord Injuries, Vascular Malformations

NCT05397106 2026-02-27

Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve

Integra LifeSciences Corporation

Active not recruiting
160 enrolled
CNS

Hemorrhagic Stroke, Brain Neoplasms, Hydrocephalus, Hydrocephalus, Normal Pressure, Pseudotumor Cerebri

Data powered by HemOnc (CC BY 4.0) Colophon âš¡